Terms: = Squamous Cell Carcinoma AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Diagnosis
337 results:
1. Real-World Biomarker Test Ordering Practices in Non-Small cell Lung Cancer: Interphysician Variation and Association With Clinical Outcomes.
Baron JM; Widatalla S; Gubens MA; Khalil F
JCO Precis Oncol; 2024 Aug; 8():e2400039. PubMed ID: 39208373
[TBL] [Abstract] [Full Text] [Related]
2. Machine learning enabled classification of lung cancer cell lines co-cultured with fibroblasts with lightweight convolutional neural network for initial diagnosis.
Germain A; Sabol A; Chavali A; Fitzwilliams G; Cooper A; Khuon S; Green B; Kong C; Minna J; Kim YT
J Biomed Sci; 2024 Aug; 31(1):84. PubMed ID: 39180048
[TBL] [Abstract] [Full Text] [Related]
3. 'Plasma first' approach for detecting epidermal growth factor receptor mutation in advanced non-small cell lung carcinoma.
Rathor A; Malik PS; Tanwar P; Khurana S; Baskarane H; Pushpam D; Nambirajan A; Jain D
J Cancer Res Clin Oncol; 2024 Jul; 150(7):371. PubMed ID: 39066920
[TBL] [Abstract] [Full Text] [Related]
4. Porocarcinoma: Clinical and Histological Features, Immunohistochemistry and Outcomes: A Systematic Review.
Bienstman T; Güvenç C; Garmyn M
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891945
[TBL] [Abstract] [Full Text] [Related]
5. Regional differences in predictive biomarker testing rates for patients with metastatic NSCLC in the Netherlands.
de Jager VD; Cajiao Garcia BN; Kuijpers CCHJ; de Bock GH; Maas WJ; Timens W; van Kempen LC; van der Wekken AJ; Schuuring E; Willems SM
Eur J Cancer; 2024 Jul; 205():114125. PubMed ID: 38788285
[TBL] [Abstract] [Full Text] [Related]
6. Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases.
Hwang A; Kwon A; Miller CH; Reimer-Taschenbrecker A; Paller AS
Orphanet J Rare Dis; 2024 May; 19(1):206. PubMed ID: 38769503
[TBL] [Abstract] [Full Text] [Related]
7. The value of dynamic FDG PET/CT in the differential diagnosis of lung cancer and predicting egfr mutations.
Wumener X; Zhang Y; Zang Z; Du F; Ye X; Zhang M; Liu M; Zhao J; Sun T; Liang Y
BMC Pulm Med; 2024 May; 24(1):227. PubMed ID: 38730287
[TBL] [Abstract] [Full Text] [Related]
8. Completion of Pembrolizumab in Advanced Non-Small cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT).
Fantoni A; Warburton L; Solomon B; Alexander M; Maddula M; Brown LJ; da Silva IP; Nagrial A; Abu Al-Hial F; Itchins M; Pavlakis N; Bowyer S
Clin Lung Cancer; 2024 Jul; 25(5):449-459. PubMed ID: 38705835
[TBL] [Abstract] [Full Text] [Related]
9. Real-World Treatment Patterns and Clinical Outcomes After Platinum-Doublet Chemotherapy and Immunotherapy in Metastatic Non-Small cell Lung Cancer: A Multiregional Chart Review in the United States, Europe, and Japan.
Leal TA; Dasgupta A; Latremouille-Viau D; Rossi C; Rai P; Barlesi F; Liu SV
JCO Glob Oncol; 2024 Mar; 10():e2300483. PubMed ID: 38484195
[TBL] [Abstract] [Full Text] [Related]
10. Serine/threonine-protein kinase D2-mediated phosphorylation of DSG2 threonine 730 promotes esophageal squamous cell carcinoma progression.
Liu YQ; Xu YW; Zheng ZT; Li D; Hong CQ; Dai HQ; Wang JH; Chu LY; Liao LD; Zou HY; Li EM; Xie JJ; Fang WK
J Pathol; 2024 May; 263(1):99-112. PubMed ID: 38411280
[TBL] [Abstract] [Full Text] [Related]
11. Correlation of MRI quantitative perfusion parameters with egfr, VEGF and egfr gene mutations in non-small cell cancer.
Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
[TBL] [Abstract] [Full Text] [Related]
12. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
[TBL] [Abstract] [Full Text] [Related]
13. Epidemiology and Outcomes of Non-Small cell Lung Cancer in South Korea.
Jung HA; Lee DH; Lim SM; Yu H; Yoon S; Kim D; Kim KP; Jeong H; Doh H; Lim S; Kim J; Zhao X; Horsburgh D; Patel D; Kim JA; Toh KC
JAMA Netw Open; 2024 Feb; 7(2):e2355331. PubMed ID: 38334998
[TBL] [Abstract] [Full Text] [Related]
14. Mutation profile and programmed death ligand 1 status of patients with non-small cell lung cancer diagnosed with "adenocarcinoma" and "non-small cell carcinoma favor adenocarcinoma".
Shigeta N; Yokose T; Murakami S; Isaka T; Shinada K; Yoshioka E; Narita A; Katakura K; Kondo T; Kato T; Nagashima T; Saito H; Ito H
Thorac Cancer; 2024 Feb; 15(6):458-465. PubMed ID: 38197164
[TBL] [Abstract] [Full Text] [Related]
15. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of egfr/PI3K/AKT/mTOR pathway.
Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
[TBL] [Abstract] [Full Text] [Related]
16. Survival Outcomes of Metastatic Non-small cell Lung Cancer Patients With Limited Access to Immunotherapy and Targeted Therapy in a Cancer Center of a Low- and Middle-Income Country.
Ballén DF; Carvajal-Fierro CA; Beltrán R; Alarcón ML; Vallejo-Yepes C; Brugés-Maya R
Cancer Control; 2023; 30():10732748231189785. PubMed ID: 37537995
[TBL] [Abstract] [Full Text] [Related]
17. A new method for oral cancer biomarkers detection with a non-invasive cyto-salivary sampling and rapid-highly sensitive ELISA immunoassay: a pilot study in humans.
Rebaudi F; De Rosa A; Greppi M; Pistilli R; Pucci R; Govoni FA; Iacoviello P; Broccolo F; Tomasello G; Pesce S; Laganà F; Bianchi B; Di Gaudio F; Rebaudi A; Marcenaro E
Front Immunol; 2023; 14():1216107. PubMed ID: 37483588
[TBL] [Abstract] [Full Text] [Related]
18. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
19. Identify the Clinicopathological Characteristics of Lung carcinoma Patients Being False Negative in Folate Receptor Based Circulating Tumor cell Detection.
Jiang S; Wang H; Zhu J; Xu X; Chen L; Wang B; Zhou B; Zhu Y; Zhang Z; Ma B; Du B; Yang Y
Small Methods; 2023 Sep; 7(9):e2300055. PubMed ID: 37330646
[TBL] [Abstract] [Full Text] [Related]
20. Incidence, trends, and survival of oropharyngeal squamous cell cancer in Aotearoa New Zealand, 2006-2020.
Win Myint TT; McIvor N; Douglas R; Tin Tin S; Elwood M
Cancer Epidemiol; 2023 Aug; 85():102393. PubMed ID: 37267678
[TBL] [Abstract] [Full Text] [Related]
[Next]
